SCHEMBL2611941

SCHEMBL2611941

Cc1ccc(-c2nc3ccccn3c2NC2CCCCC2)c(O)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 1/20 0.71
ALOX5 P09917 4/20 0.69
SALL4 Q9UJQ4 2/20 0.61
TRIM33 Q9UPN9 4/20 0.60
TRIM24 O15164 2/20 0.60
ALDH1A1 P00352 4/20 0.57
GAA P10253 3/20 0.57
KDM4E B2RXH2 2/20 0.57
GFER P55789 2/20 0.57
MAPT P10636 1/20 0.56
MAPK1 P28482 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
BRD4 O60885 1/20 0.56
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2D6 P10635 1/20 0.56
CYP2C9 P11712 1/20 0.56
CYP2C19 P33261 1/20 0.56
LMNA P02545 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2611922 0.89 SALL4 (0.64) ADORA1ALOX5SALL4TRIM33TRIM24
SCHEMBL1965729 0.88 ALOX5 (0.72) ADORA1ALOX5SALL4TRIM33TRIM24
SCHEMBL2986458 0.86 ALOX5 (0.70) ADORA1ALOX5SALL4TRIM33TRIM24
SCHEMBL20889569 0.84 SALL4 (0.67) ADORA1ALOX5SALL4TRIM33TRIM24
SCHEMBL2984312 0.83 ALOX5 (0.70) ADORA1ALOX5SALL4ALDH1A1GAA
SCHEMBL2977991 0.83 ADORA1 (1.00) ADORA1ALOX5TRIM33TRIM24ALDH1A1
SCHEMBL15172137 0.83 ADORA1 (0.71) ADORA1ALOX5SALL4TRIM33TRIM24
SCHEMBL15172138 0.82 ADORA1 (0.69) ADORA1ALOX5SALL4TRIM33TRIM24
SCHEMBL2983996 0.81 ALOX5 (1.00) ADORA1ALOX5ALDH1A1GAAKDM4E
SCHEMBL1967827 0.79 ADORA1 (0.59) ADORA1ALOX5SALL4TRIM33TRIM24

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120101122-A1 IMIDAZO[1,2 A] PYRIDINE 6 CARBOXAMIDE DERIVATIVES, THEIR USE FOR THE TREATMENT OF COLON CANCER AND THEIR METHOD OF MANUFACTURE UNIVERSITY OF THE WITWATERSRAND, JOHANNESBURG (ZA) 2012-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120101122-A1 IMIDAZO[1,2 A] PYRIDINE 6 CARBOXAMIDE DERIVATIVES, THEIR USE FOR THE TREATMENT OF COLON CANCER AND THEIR METHOD OF MANUFACTURE H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, MCL1, CBR1 ADORA1 714/4885ALOX5 2223/4885SALL4 2382/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.